Results 261 to 270 of about 2,150,188 (381)
Mesoscale connectivity of the human hippocampus and fimbria revealed by ex vivo diffusion MRI. [PDF]
McCrea M+7 more
europepmc +1 more source
Neonatal Cerebral Infarction Diagnosed by Diffusion-Weighted MRI
Irina Mader+3 more
openalex +1 more source
Removal of intensity bias in magnitude spin-echo MRI images by nonlinear diffusion filtering [PDF]
Alexey Samsonov, Chris R. Johnson
openalex +1 more source
Mucosal‐associated invariant T cells in rheumatic diseases.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor (TCR) and restriction by the MHC class I‐related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines. Upon activation, MAIT cells rapidly produce pro‐inflammatory cytokines,
Manon Lesturgie‐Talarek+7 more
wiley +1 more source
Relationship between sodium and diffusion MRI metrics in multiple sclerosis. [PDF]
Cipriano E+11 more
europepmc +1 more source
Clinical Application of Diffusion-weighted MRI of the Brain - CME-Questionaire [PDF]
Jochen B. Fiebach, Inga Harting
openalex +1 more source
Confirmation of a gyral bias in diffusion MRI fiber tractography
K. Schilling+5 more
semanticscholar +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Summary Castleman disease (CD) is a major diagnostic challenge for Rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y.C. Chen+2 more
wiley +1 more source
X‐ray controlled release strategy in cancer therapy
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan+5 more
wiley +1 more source